Valley Tree
An obscure modern hybrid with limited documentation, often confused with similarly-named cuts and lacking independent lab verification.
Valley Tree is one of those strain names that circulates on menus and seed forums without much paper trail. There are no peer-reviewed studies on it, no consistent breeder documentation, and no independent chemovar data we can point to. Anything you read about its 'effects profile' is essentially crowdsourced vibes filtered through marketing. If a budtender pitches it as a distinct experience, treat that as a sales claim, not pharmacology. Buy it because the specific jar in front of you smells and tests well, not because of the name.
Overview
Valley Tree is a cannabis strain name that appears on dispensary menus and in seed-trading communities, but it has no widely-documented breeder of record, no peer-reviewed chemovar analysis, and no consistent lineage claim across sources. No data
This is common in modern cannabis: of the thousands of strain names in circulation, only a small fraction have verifiable genetic and chemical documentation. A 2015 genetic study of commercial cannabis samples found that strain names frequently do not correspond to genetically distinct populations, and that samples sold under the same name can differ substantially [1]. A larger 2022 analysis reached similar conclusions, showing that the commercial 'strain' label is a poor predictor of genotype or chemotype [2].
In other words: even if 'Valley Tree' exists as a real cut somewhere, what's labeled Valley Tree at any given shop may or may not be the same plant.
Chemistry: Cannabinoids and Terpenes
We have no independent certificate-of-analysis dataset for Valley Tree to cite. Any THC, CBD, or terpene numbers you see attached to this name on retail menus come from individual batch tests of single jars and are not generalizable to the strain. No data
What we can say generally:
- Modern hybrid flower in legal markets typically tests in the 15–25% THC range, with CBD usually under 1% unless specifically bred for it [3].
- Terpene profiles in commercial cannabis cluster into a few broad chemovar groups dominated by myrcene, caryophyllene, limonene, or terpinolene [2].
- The popular notion of a 'myrcene threshold' (e.g. the claim that >0.5% myrcene makes a strain sedating and 'indica-like') is folklore. It traces to a single non-peer-reviewed source and has never been validated experimentally. Disputed
If you want to know what's actually in a specific Valley Tree jar, read the COA on the label. That is the only honest answer.
Reported Effects
There is no clinical research on Valley Tree specifically, and there almost never is for any named strain. No data
User-reported effects on consumer review sites are subject to severe selection bias, placebo effects, and the well-documented unreliability of strain naming [1][2]. Anecdotal reports for Valley Tree describe a 'relaxing' or 'mellow' hybrid effect Anecdote, but identical language is applied to hundreds of other hybrid strains, which limits its informational value.
The broader, better-supported picture: subjective cannabis effects are driven primarily by total THC dose, route of administration, individual tolerance, setting, and expectation — not by strain name [4]. The indica/sativa distinction, in particular, does not reliably predict effects and is not supported by chemical or genetic data [2][5]. Strong evidence
Lineage
Lineage for Valley Tree is disputed and undocumented. Disputed No reputable breeder has published a verifiable cross, and seedbank listings (where they exist) are inconsistent.
This matters because, in cannabis, lineage is a marketing claim unless it is backed by either (a) a breeder with a documented program and preserved parent stock, or (b) genetic testing. Most strain pedigrees circulating online are unverifiable folklore [1][2]. Treat any specific parentage claim about Valley Tree — for example, that it descends from a particular OG or Cookies cut — as unconfirmed until a breeder produces records.
Cultivation Basics
Because Valley Tree lacks an established breeder record, there is no authoritative grow guide. Anything published about its flowering time, stretch, feeding preferences, or yield is extrapolated from anecdote.
General guidance that applies to any unfamiliar modern hybrid:
- Expect 8–10 weeks of flowering indoors for most photoperiod hybrids [6].
- Run a small pheno hunt if you're working from seed; phenotype variation within a single strain name can be large [2].
- Test the finished flower. A COA tells you more about what you actually grew than any strain name ever will.
If you're a hobby grower curious about Valley Tree specifically, ask the seller for documentation of the parent stock before paying a premium for the name.
Marketing vs. Reality
Strain names in cannabis function similarly to brand names — they help shops differentiate inventory and let consumers feel they're making an informed choice. But the underlying science is unflattering to that model:
- Samples sharing a strain name are often genetically distinct [1][2]. Strong evidence
- Indica/sativa labels do not predict chemical profile or effect [2][5]. Strong evidence
- THC percentage on the label is weakly correlated with subjective potency or satisfaction [7]. Weak / limited
For a name like Valley Tree, with no breeder of record and no published chemovar data, the gap between marketing and reality is even wider than usual. Our honest recommendation: ignore the name, read the COA, smell the jar, and judge by the actual product.
Sources
- Peer-reviewed Sawler, J., Stout, J. M., Gardner, K. M., et al. (2015). The Genetic Structure of Marijuana and Hemp. PLOS ONE, 10(8), e0133292.
- Peer-reviewed Watts, S., McElroy, M., Migicovsky, Z., et al. (2021). Cannabis labelling is associated with genetic variation in terpene synthase genes. Nature Plants, 7, 1330–1334.
- Peer-reviewed ElSohly, M. A., Mehmedic, Z., Foster, S., Gon, C., Chandra, S., & Church, J. C. (2016). Changes in Cannabis Potency Over the Last 2 Decades (1995–2014). Biological Psychiatry, 79(7), 613–619.
- Peer-reviewed Kruger, D. J., & Kruger, J. S. (2022). Consumer experiences with high-THC and high-CBD cannabis products. Journal of Cannabis Research, 4, 41.
- Peer-reviewed Piomelli, D., & Russo, E. B. (2016). The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD. Cannabis and Cannabinoid Research, 1(1), 44–46.
- Book Cervantes, J. (2006). Marijuana Horticulture: The Indoor/Outdoor Medical Grower's Bible. Van Patten Publishing.
- Peer-reviewed Bidwell, L. C., Ellingson, J. M., Karoly, H. C., et al. (2020). Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment. JAMA Psychiatry, 77(8), 787–796.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Myrcene — The most common monoterpene in cannabis, blamed and credited for a lot of things it probab...